Simulations Plus Boosting Growth with Tech Investments
Simulations Plus aims to boost growth through investments and partnerships, promoting innovation and increasing market opportunity. With over 25 years ...
- Latest
- Trending
Simulations Plus aims to boost growth through investments and partnerships, promoting innovation and increasing market opportunity. With over 25 years ...
Adial Pharmaceuticals acquires patent for genetic diagnostic tool to identify patients who may respond well to their lead drug AD04, ...
DLH Holdings secures $23 million contract with NIDA to provide IT services and an informatics system for drug abuse research. ...
Clinical-stage biotech company Coya Therapeutics expands its IP portfolio with a license for a novel combination therapy using low dose ...
KalVista Pharmaceuticals achieves key goals in late-stage study for hereditary angioedema therapy, demonstrating significant efficacy of sebetralstat. FDA approval filing ...
Sosei Group Corporation announces operational activities and consolidated results, including significant investment, marketing approval, and partnerships. Despite revenue decrease, the ...
Investment banking firm Jefferies raises Eli Lilly's price target based on optimism over orfoscerinib, indicating strong confidence in its potential. ...
Japanese stocks surged as the Nikkei reached a 34-year high due to strong corporate earnings and a surge in tech-related ...
Japan's Nikkei surged to a 34-year high driven by tech rally & strong earnings. Investors are optimistic about the market's ...
Otsuka's phase 3 trial for AVP-786 in treating agitation in Alzheimer's patients has failed to meet the primary efficacy endpoint. ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.